The authors concluded that inhaled and oral corticosteroids are effective in reducing serum CRP levels in patients with COPD and suggested their potential use in improving cardiovascular outcomes in COPD [64]. This evidence concerns the gene CRP and chronic obstructive pulmonary disease.